John Fung to Antibodies, Monoclonal
This is a "connection" page, showing publications John Fung has written about Antibodies, Monoclonal.
Connection Strength
0.802
-
Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. Transplantation. 2005 Dec 27; 80(12):1692-8.
Score: 0.175
-
Impact of Orthoclone OKT3 on liver transplantation. Transplant Proc. 1987 Apr; 19(2 Suppl 1):37-44.
Score: 0.048
-
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron. 1987; 46 Suppl 1:19-33.
Score: 0.047
-
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. Transplantation. 2006 Dec 27; 82(12):1621-4.
Score: 0.047
-
Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection. Transplantation. 2006 Dec 27; 82(12):1649-52.
Score: 0.047
-
Immunosuppression in liver transplantation: beyond calcineurin inhibitors. Liver Transpl. 2005 Mar; 11(3):267-80.
Score: 0.041
-
Reversal of acute cellular rejection after renal transplantation with Campath-1H. Transplant Proc. 2005 Mar; 37(2):923-6.
Score: 0.041
-
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation. 2004 Dec 15; 78(11):1683-8.
Score: 0.041
-
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation. 2004 Oct 15; 78(7):966-71.
Score: 0.040
-
Neutralization of IL-12 reverses rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with suppression of both cellular and humoral responses. Transplant Proc. 2001 Feb-Mar; 33(1-2):525.
Score: 0.031
-
Immunosuppressive therapy. Surg Clin North Am. 1999 Feb; 79(1):59-76.
Score: 0.027
-
Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival. Transplant Proc. 1999 Feb-Mar; 31(1-2):1242-3.
Score: 0.027
-
Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1244.
Score: 0.027
-
Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Transplantation. 1998 Dec 27; 66(12):1587-96.
Score: 0.027
-
Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation. 1997 Dec 27; 64(12):1838-43.
Score: 0.025
-
Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway. Transplantation. 2013 Jul 15; 96(1):17-24.
Score: 0.018
-
Effect of OKT3 on survival and rate of retransplantation. Transplant Proc. 1987 Aug; 19(4 Suppl 3):61-2.
Score: 0.012
-
OKT3 in the reversal of acute hepatic allograft rejection. Transplant Proc. 1987 Feb; 19(1 Pt 3):2443-6.
Score: 0.012
-
Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants. Nephron. 1987; 46 Suppl 1:56-9.
Score: 0.012
-
Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol. 2003 Aug; 64(8):787-95.
Score: 0.009
-
The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc. 2000 Sep; 32(6):1197-8.
Score: 0.008
-
Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation. 1999 Sep 27; 68(6):747-57.
Score: 0.007
-
Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection. Transplant Proc. 1998 Jun; 30(4):941-2.
Score: 0.006
-
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation. 1997 Dec 27; 64(12):1808-15.
Score: 0.006
-
Patterns of inflammatory vascular endothelial changes in murine liver grafts. Transplantation. 1995 Sep 27; 60(6):577-84.
Score: 0.005
-
A simplified method for growing dendritic cells from rat bone marrow. Adv Exp Med Biol. 1995; 378:53-5.
Score: 0.005
-
Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology. 1991 Feb; 13(2):239-46.
Score: 0.004
-
Assay of FK 506 in plasma. Transplant Proc. 1990 Feb; 22(1):50-1.
Score: 0.004